Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Cash

by Benzinga Staff
January 8, 2013 4:07 AM | 1 min read

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of cash.Forest Laboratories (NYSE: FRX) had $2.12 billion in total cash and no debt for the latest quarter.Cubist Pharmaceuticals (NASDAQ: CBST) had $896.96 million in total cash for the latest quarter. However, Cubist Pharmaceuticals had $400.87 million in total debt for the same period.United Therapeutics (NASDAQ: UTHR) had $503.46 million in total cash and $273.37 million in total debt for the latest quarter.Taro Pharmaceutical Industries (NYSE: TARO) had $411.82 million in total cash and $37.65 million in total debt for the latest quarter.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Trading IdeasDrug Manufacturers-Other Industryhighest cashmid-cap stocks

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.